Literature DB >> 12067484

Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.

A Cedazo-Mínguez1, R F Cowburn.   

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative disorder with multiple etiologies. The presence of the E4 isoform of apolipoprotein E (apoE) has been shown to increase the risk and to decrease the age of onset for AD and is the major susceptibility factor known for the disease. ApoE4 has been shown to intensify all the biochemical disturbances characteristic of AD, including beta amyloid (Abeta) deposition, tangle formation, neuronal cell death, oxidative stress, synaptic plasticity and dysfunctions of lipid homeostasis and cholinergic signalling. In contrast, other apoE isoforms are protective. Here we review and discuss these major hypotheses of the apoE4-AD association.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12067484      PMCID: PMC6514775          DOI: 10.1111/j.1582-4934.2001.tb00159.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  24 in total

Review 1.  Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Authors:  Latha Devi; Badanavalu M Prabhu; Domenico F Galati; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

Review 3.  Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.

Authors:  D Allan Butterfield; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2020-02-06       Impact factor: 5.996

4.  Dementia Risk and Financial Decision Making by Older Households: The Impact of Information.

Authors:  Joanne W Hsu; Robert Willis
Journal:  J Hum Cap       Date:  2013-04-01

Review 5.  Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.

Authors:  Xianlin Han
Journal:  J Neurochem       Date:  2007-11       Impact factor: 5.372

6.  A candidate gene study of risk for dementia in older, postmenopausal women: Results from the Women's Health Initiative Memory Study.

Authors:  Ira Driscoll; Beverly M Snively; Mark A Espeland; Sally A Shumaker; Stephen R Rapp; Joseph S Goveas; Ramon L Casanova; Jean Wactawski-Wende; JoAnn E Manson; Rebecca Rossom; Janet Brooks; Dena G Hernandez; Andrew B Singleton; Susan M Resnick
Journal:  Int J Geriatr Psychiatry       Date:  2019-03-07       Impact factor: 3.485

Review 7.  Alzheimer's disease - the ways of prevention.

Authors:  M Kivipelto; A Solomon
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

8.  Sulfatides facilitate apolipoprotein E-mediated amyloid-beta peptide clearance through an endocytotic pathway.

Authors:  Youchun Zeng; Xianlin Han
Journal:  J Neurochem       Date:  2008-05-13       Impact factor: 5.372

9.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

10.  Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats.

Authors:  Ling Shen; Patrick Tso; David Q-H Wang; Stephen C Woods; W Sean Davidson; Randall Sakai; Min Liu
Journal:  Physiol Behav       Date:  2009-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.